Grand River Cardiology p.c.,
Grand Rapids, Mich
To the Editor:
I would like to compliment Dr Eagle and colleagues on an excellent
article regarding cardiovascular risk of patients with
coronary artery disease undergoing noncardiac surgery,
published recently in Circulation.1 I do
take issue, however, with the general statement that coronary
revascularization done before the planned procedure
is effective in reducing the risk of postoperative myocardial
infarction and/or death.
Although retrospective studies, including the CASS registry patients
used in Dr Eagle's study, have shown a low mortality rate after
noncardiac surgical procedures in patients who have undergone
coronary bypass surgery, I do not believe that
percutaneous revascularization
procedures have been shown to be similarly effective. Again,
retrospective studies have been done, such as the one by Huber et
al2 from Mayo Clinic, that have not clearly shown
whether PTCA is also "protective".
It has been my perception that many angioplasty procedures are being
performed, especially now with the widespread use of stenting, on
patients who have been found by intensive preoperative testing and
screening to have obstructive coronary disease, with the belief
that the risk of surgery will be reduced. The article by Eagle et al
may unintentionally foster behavior that is possibly inappropriate by
not making a more clear distinction between surgical and
percutaneous revascularization.
References
1.
Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED,
Gersh BJ, for the CASS Investigators and University of Michigan Heart
Care Program. Cardiac risk of noncardiac surgery: influence of
coronary disease and type of surgery in 3368 operations.
Circulation. 1997;96:18821887.
2.
Huber KC, Evans MA, Bresnahan JF, Gibbons RJ, Holmes
DR Jr. Outcome of noncardiac operations in patients with severe
coronary artery disease successfully treated preoperatively
with coronary angioplasty. Mayo Clin Proc. 1992;67:1521.[Medline]
[Order article via Infotrieve]
Albion Walter Hewlett Professor of Internal Medicine and Senior
Associate Chair Department of Internal Medicine,
Chief of Clinical Cardiology,
Division of Cardiology,
University of Michigan,
Ann Arbor, Mich
As Dr Miller points out, the prophylactic
application of coronary angiography and related procedures for
the expressed purpose of lowering coronary risk for noncardiac
surgery remains ill defined. There have been at least 3 nonrandomized
trials1 2 3 that suggest, on average, that
patients
© 1998 American Heart Association, Inc.
Correspondence
Cardiac Risk of Noncardiac Surgery
Response
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |